Advertisement

Advertisement

TRAW Stock Latest News

Traws Pharma Advances Broad-Spectrum Antiviral for Emerging Outbreaks

Company AnnouncementsTraws Pharma Advances Broad-Spectrum Antiviral for Emerging Outbreaks

Traws Pharma announces antiviral program targeting Hantavirus, Ebola

PremiumThe Fly

Traws Pharma announces antiviral program targeting Hantavirus, Ebola

11d ago

Traws Pharma Updates ATM Equity Offering Prospectus Supplements

PremiumCompany Announcements

Traws Pharma Updates ATM Equity Offering Prospectus Supplements

12d ago

Traws Pharma Highlights Q1 Results and Antiviral Pipeline Progress

PremiumCompany Announcements

Traws Pharma Highlights Q1 Results and Antiviral Pipeline Progress

23d ago

Traws Pharma files to sell 35.9M shares of common stock for holders

PremiumThe Fly

Traws Pharma files to sell 35.9M shares of common stock for holders

30d ago

Traws Pharma, United Rentals, Huntington, Sprouts, Verisign Insider Shake-Up

PremiumWeekend UpdatesTraws Pharma, United Rentals, Huntington, Sprouts, Verisign Insider Shake-Up

1M ago

Traws Pharma Reports 2025 Results, Secures PIPE Financing

Company Announcements

Traws Pharma Reports 2025 Results, Secures PIPE Financing

2M ago

Traws Pharma Secures PIPE Financing for Influenza Trial

Company Announcements

Traws Pharma Secures PIPE Financing for Influenza Trial

2M ago

Traws Pharma Delays 10-K Amid Financing Review

PremiumCompany Announcements

Traws Pharma Delays 10-K Amid Financing Review

2M ago

Traws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data

PremiumCompany Announcements

Traws Pharma Highlights Positive Ratutrelvir Phase 2 COVID-19 Data

4M ago

Traws Pharma completes clinical analysis of Phase 2 study of ratutrelvir

PremiumThe Fly

Traws Pharma completes clinical analysis of Phase 2 study of ratutrelvir

4M ago

Traws Pharma initiated with a Buy at Ladenburg

PremiumThe Fly

Traws Pharma initiated with a Buy at Ladenburg

4M ago

Traws Pharma Completes Phase 2 Enrollment for COVID Candidate

PremiumCompany AnnouncementsTraws Pharma Completes Phase 2 Enrollment for COVID Candidate

4M ago

Traws Pharma completes enrollment in Phase 2 study of ratutrelvir

The Fly

Traws Pharma completes enrollment in Phase 2 study of ratutrelvir

4M ago

Traws Pharma’s TRX-100 Phase 1 Completion: A Quiet but Key Milestone for Investors

Company Announcements

Traws Pharma’s TRX-100 Phase 1 Completion: A Quiet but Key Milestone for Investors

5M ago

Traws Pharma advances flu and COVID-19 antiviral pipeline

PremiumCompany Announcements

Traws Pharma advances flu and COVID-19 antiviral pipeline

5M ago

Traws Pharma files tivoxavir marboxil IND application with U.S. FDA

PremiumThe Fly

Traws Pharma files tivoxavir marboxil IND application with U.S. FDA

5M ago

Promising Phase 2 Results for Ratutrelvir Highlight Clinical and Market Differentiation in COVID-19 Treatment

PremiumRatings

Promising Phase 2 Results for Ratutrelvir Highlight Clinical and Market Differentiation in COVID-19 Treatment

6M ago

Traws Pharma Reports Positive Phase 2 Trial Results

PremiumCompany Announcements

Traws Pharma Reports Positive Phase 2 Trial Results

6M ago

Traws Pharma reports ‘positive’ interim data with ratutrelvir vs. paxlovid

PremiumThe FlyTraws Pharma reports ‘positive’ interim data with ratutrelvir vs. paxlovid

6M ago

Traws Pharma Approves Executive Stock Options

Company Announcements

Traws Pharma Approves Executive Stock Options

6M ago

Traws Pharma initiated with a Buy at H.C. Wainwright

The Fly

Traws Pharma initiated with a Buy at H.C. Wainwright

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >